Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non–Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial-Reference-Cited by-同舟云学术

Canakinumab as Adjuvant Therapy in Patients With Completely Resected Non–Small-Cell Lung Cancer: Results From the CANOPY-A Double-Blind, Randomized Clinical Trial

Published:2024-01-10 Issue:2 Volume:42 Page:180-191
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Garon Edward B.¹^ORCID,Lu Shun²^ORCID,Goto Yasushi³^ORCID,De Marchi Pedro⁴^ORCID,Paz-Ares Luis⁵^ORCID,Spigel David R.⁶^ORCID,Thomas Michael⁷^ORCID,Yang James Chih-Hsin⁸^ORCID,Ardizzoni Andrea⁹,Barlesi Fabrice¹⁰¹¹,Orlov Sergey¹²^ORCID,Yoshioka Hiroshige¹³^ORCID,Mountzios Giannis¹⁴,Khanna Sadhvi¹⁵,Bossen Claudia¹⁶,Carbini Mariana¹⁶,Turri Sabine¹⁵,Myers Andrea¹⁷,Cho Byoung Chul¹⁸^ORCID

Affiliation:

1. David Geffen School of Medicine at UCLA/TRIO-US/TRIO-Global Network, Los Angeles, CA

2. Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

3. National Cancer Center, Tokyo, Japan

4. Oncoclinicas, Rio de Janeiro, Brazil

5. University Hospital 12 de Octubre, CNIO-H120 Lung Cancer Unit, Completense University and Ciberonc, Madrid, Spain

6. Sarah Cannon Research Institute, Nashville, TN

7. Thoraxklinik and National Center for Tumor Diseases at Heidelberg University Hospital, Translational Lung Research Center Heidelberg (TLRH-C), German Center for Lung Research (DZL), Heidelberg, Germany

8. National Taiwan University Cancer Center and National Taiwan University Hospital, Taipei, Taiwan

9. IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

10. Medical Oncology Department, Gustave Roussy, Villejuif, France

11. Faculté de Médecine, Université Paris-Saclay, Bicêtre, France

12. Saint Petersburg Electrotechnical University, Saint Petersburg, Russia

13. Department of Thoracic Oncology, Kansai Medical University, Hirakata, Japan

14. Fourth Oncology Department and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece

15. Novartis Pharma S.A.S, Rueil-Malmaison, France

16. Novartis Pharma AG, Basel, Switzerland

17. Novartis Pharmaceuticals Corporation, East Hanover, NJ

18. Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea

Abstract